2018 Blood Transfusion Market - Global Forecasts to 2023: Driven by Rise in Accidental Cases, Growing Number of Procedures, M&A Activities - ResearchAndMarkets.com

DUBLIN--()--The "Global Blood Transfusion Market - Segmented by Product, End User, and Geography - Growth, Trends, and Forecast (2018 - 2023)" report has been added to ResearchAndMarkets.com's offering.

The global blood transfusion market is expected to witness a CAGR of 4.9% during the forecast period (2018-2023). The market is growing at a fast pace with the rise in accidental cases, the growing number of blood transfusion procedures, competition, and M&A activities.

Trauma is considered to be the foremost cause of death and approximately 180,000 people die with trauma every year. Up to 45% of the polytrauma patients die as a result of circulatory shock from acute blood loss. The World Health Organization states that the burden of the diseases related to injuries are mostly the road traffic injuries, accidents, etc., and these accidents are expected to rise dramatically by the year 2020. Each year 1.25 million people die because of these road accidents and a large amount of blood is being lost which requires blood transfusion and ultimately leads to the growth of the market.

The other factors including the automation in blood processing equipment, the increase in the R&D initiatives for regenerative medicine, the increasing number of surgical procedures, and the rise in the number of blood disorders are also contributing to the growth of the market.

Geographically, North America is expected to dominate the market, owing to its well-developed healthcare industry and a rise in the number of patient's population requiring the blood. However, the Asia-Pacific region is also projected to grow at the highest growth rate due to the rising government initiatives for the improvement of the healthcare facilities and increase in the number of blood banks.

Key Topics Covered

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

7. Market Segmentation

8. Competitive Landscape

9. Key Players

  • Abbott
  • Macopharma
  • Becton Dickinson
  • B. Braun Melsungen AG
  • Terumo Medical Corporation
  • Haemonetics Corporation
  • Fresenius Kabi AG
  • Immucor
  • Kidde-Fenwal Inc.

10. Future of the Market

For more information about this report visit https://www.researchandmarkets.com/research/5cgxhd/2018_blood?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Blood Banking

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Blood Banking